Radnor Capital Management LLC boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 4,122.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,343 shares of the biotechnology company’s stock after purchasing an additional 53,056 shares during the quarter. Axon Enterprise comprises about 3.1% of Radnor Capital Management LLC’s investment portfolio, making the stock its 4th largest holding. Radnor Capital Management LLC’s holdings in Axon Enterprise were worth $22,961,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in AXON. Norris Perne & French LLP MI acquired a new stake in Axon Enterprise in the third quarter worth $2,906,000. Signaturefd LLC raised its position in Axon Enterprise by 7,380.5% in the 3rd quarter. Signaturefd LLC now owns 78,770 shares of the biotechnology company’s stock valued at $33,282,000 after buying an additional 77,717 shares during the last quarter. Citizens Financial Group Inc. RI lifted its position in shares of Axon Enterprise by 13,919.9% in the third quarter. Citizens Financial Group Inc. RI now owns 111,038 shares of the biotechnology company’s stock worth $46,916,000 after purchasing an additional 110,246 shares in the last quarter. Sowell Financial Services LLC boosted its stake in shares of Axon Enterprise by 1,652.0% during the 3rd quarter. Sowell Financial Services LLC now owns 142,492 shares of the biotechnology company’s stock worth $60,206,000 after buying an additional 134,359 shares during the last quarter. Finally, Ascent Wealth Partners LLC grew its stake in Axon Enterprise by 308.2% in the third quarter. Ascent Wealth Partners LLC now owns 66,568 shares of the biotechnology company’s stock valued at $28,126,000 after purchasing an additional 50,260 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Morgan Stanley raised their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research report on Tuesday, October 13th. Argus boosted their price objective on Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Finally, The Goldman Sachs Group decreased their target price on Axon Enterprise from $715.00 to $675.00 and set a “buy” rating on the stock in a research report on Monday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $689.94.
Read Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Performance
Shares of Axon Enterprise stock opened at $420.37 on Friday. The company’s 50 day moving average price is $480.64 and its two-hundred day moving average price is $473.90. The firm has a market capitalization of $34.15 billion, a P/E ratio of 174.43, a P/E/G ratio of 7.99 and a beta of 1.44. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $764.02. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business’s quarterly revenue was up 35.3% on a year-over-year basis. During the same period last year, the company earned $2.12 earnings per share. On average, equities analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.
Insider Activity
In other news, insider Jeffrey Kunins sold 9,605 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares in the company, valued at $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 47,397 shares of company stock worth $26,722,984. 4.20% of the stock is owned by company insiders.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
